P Perini

Interferon-beta (INF-beta) antibodies in interferon-beta1a- and interferon-beta1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo.

P. Gallo, A. Bertolotto, P. Perini, 2001, European cytokine network.

The predictive value of gray matter atrophy in clinically isolated syndromes

M. Calabrese, P. Gallo, F. Rinaldi, 2011, Neurology.

Widespread cortical thinning characterizes patients with MS with mild cognitive impairment

M. Calabrese, C. Romualdi, P. Gallo, 2010, Neurology.

Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing–remitting multiple sclerosis

M. Calabrese, P. Gallo, M. Atzori, 2012, Multiple sclerosis.

Gray Matter Pathology in MS: A 3-Year Longitudinal Study in a Pediatric Population

M. Calabrese, C. Romualdi, P. Gallo, 2012, American Journal of Neuroradiology.